On May 12, 2024, Rundu Co., Ltd. disclosed in the interactive exchange of the Shenzhen Stock Exchange that as of May 10, 2024, the number of shareholders of the company was 14,700, a decrease of 530 or 3.48% from the previous period (April 10, 2024).
The number of shareholders of Rundu shares is lower than the industry average. According to Choice data, as of May 10, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 33,900. Among them, the number of shareholders of the company is in the range of 5,000 ~ 15,000, accounting for the highest proportion, 29.05%, and Rundu shares are also in the range.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since March 20, 2024, the number of shareholders of the company has decreased, with a decrease of 5.18%. From March 20, 2024 to May 10, 2024, the stock price rose by 1.35%.
Number of shareholders and share price
Number of shareholders and share capital
As of May 10, 2024, the company's latest total share capital is 335 million shares, of which the outstanding share capital is 258 million shares. The average number of outstanding shares held by households increased from 16,900 shares in the previous period to 17,600 shares, and the average market value of households was 197,100 yuan.
The average amount of shares held by each household
The market value of Rundu shares held by each shareholder is lower than the industry average. According to Choice data, as of May 10, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 401,600 yuan. Among them, 25.10% of the company's households hold a circulating stock market value in the range of 130,000 ~ 250,000, and Rundu shares are also in the range.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.